13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:01:21 UTC, with 121 holding rows worth $2,457,611,956.
- Accession
- 0001011438-26-000687
- Filer
- CIK 1773195
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 121 entries on the cover page, a total value of $2,457,611,956 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,457,611,956 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 464287655 | SHS | 1,000,000 | $277,890,000 | dollars as filed | put |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,200,000 | $117,024,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,279,134 | $113,881,300 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 600,000 | $94,608,000 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 5,590,600 | $81,958,196 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 2,080,000 | $73,715,200 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,900,374 | $70,674,909 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 564,251 | $64,403,609 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 1,565,000 | $63,413,800 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 325,000 | $62,585,250 | dollars as filed | put |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 1,000,000 | $54,220,000 | dollars as filed | put |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 950,000 | $51,509,000 | dollars as filed | call |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 600,000 | $49,974,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 3,244,861 | $49,743,719 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 750,000 | $49,432,500 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 250,000 | $48,142,500 | dollars as filed | call |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 225,000 | $46,183,500 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 155,000 | $45,140,650 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 242,088 | $41,111,384 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 4,308,700 | $40,674,128 | dollars as filed | put |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,160,499 | $37,611,773 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 330,000 | $32,676,600 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 350,000 | $30,817,500 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 1,700,000 | $28,747,000 | dollars as filed | put |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 1,260,000 | $27,997,200 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 425,000 | $27,816,250 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,800,172 | $25,778,463 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 10,144,562 | $25,259,959 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 2,527,384 | $24,970,554 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 615,400 | $24,936,008 | dollars as filed | call |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 7,245,611 | $24,490,165 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 172,125 | $24,250,691 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 967,620 | $22,942,270 | dollars as filed | |
| OMEROS CORP | 682143AK8 | NOTE 9.500% 6/1 | 6,525,000 | $21,205,656 | dollars as filed | principal |
| VOGENX INC | 92859A106 | COM | 915,000 | $20,852,850 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 750,000 | $18,847,500 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 850,000 | $18,589,500 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 1,152,487 | $18,566,566 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 300,000 | $17,664,000 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 643,343 | $16,424,547 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 2,050,000 | $15,856,750 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 1,716,320 | $15,618,512 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 850,000 | $15,342,500 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 30,000 | $15,118,800 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 875,760 | $13,442,916 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 2,512,153 | $12,962,709 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 420,000 | $12,952,800 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240QAA0 | NOTE 1.625%11/1 | 11,000,000 | $12,054,793 | dollars as filed | principal |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 972,000 | $11,148,840 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 1,180,000 | $11,139,200 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 450,000 | $11,002,500 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 3,988,744 | $10,969,046 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 760,350 | $10,682,918 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 2,600,000 | $10,166,000 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 175,000 | $9,681,000 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 79,400 | $9,625,662 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 149,779 | $9,611,318 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 300,000 | $8,730,000 | dollars as filed | |
| KORSANA BIOSCIENCES INC | 23255M303 | COMMON STOCK | 263,106 | $8,419,392 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 4,970,074 | $8,250,323 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 250,000 | $8,072,500 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 375,000 | $7,980,000 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 735,538 | $7,965,877 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 105,000 | $7,799,400 | dollars as filed | |
| Celcuity Inc Note 0.250 percent 8/0 | 15102KAB6 | Convertible | 8,000,000 | $7,751,002 | dollars as filed | principal |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 200,000 | $7,684,000 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 912,397 | $7,089,325 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 350,000 | $6,814,500 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 148,000 | $6,784,320 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 275,000 | $6,688,000 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 625,000 | $6,637,500 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 2,062,500 | $5,981,250 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 353,100 | $5,307,093 | dollars as filed | put |
| KORRO BIO INC | 500946108 | COMMON STOCK | 531,904 | $5,271,169 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 250,000 | $5,147,500 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 450,000 | $4,918,500 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 4,130,427 | $4,873,904 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,000,000 | $4,870,000 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 1,525,000 | $4,834,250 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 900,000 | $4,356,000 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 144,404 | $4,294,575 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 2,613,954 | $4,247,675 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 350,000 | $4,221,000 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 250,000 | $4,175,000 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,000,000 | $4,140,000 | dollars as filed | |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 74,900 | $4,061,078 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 646,576 | $4,047,566 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 375,000 | $4,005,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 250,000 | $3,757,500 | dollars as filed | call |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 301,183 | $3,746,717 | dollars as filed | |
| RAINIER ACQUISITION CORP | G73591110 | UNIT | 364,957 | $3,722,561 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 953,979 | $3,682,359 | dollars as filed | |
| RESEARCH ALLIANCE CORP IV | G75228109 | CL A ORD SHS | 300,000 | $3,600,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $3,378,000 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 66,464 | $3,340,481 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 800,000 | $3,328,000 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 245,000 | $3,305,050 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 688,654 | $3,302,096 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 100,000 | $3,028,000 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 50,000 | $2,931,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,750,000 | $2,922,500 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 400,000 | $2,892,000 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 250,000 | $2,722,500 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 934,412 | $2,719,139 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 4,500,000 | $2,682,900 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 200,000 | $2,502,000 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 153,847 | $2,461,552 | dollars as filed | |
| EIKON THERAPEUTICS INC | 282564103 | COMMON STOCK | 298,001 | $2,395,928 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 250,000 | $2,360,000 | dollars as filed | call |
| JATT III ACQUISITION CORP | G5080G109 | COM | 211,993 | $2,336,163 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 200,000 | $2,249,000 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 1,300,000 | $1,573,000 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 100,000 | $1,502,000 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 291,960 | $1,462,720 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 300,000 | $1,152,000 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,850,000 | $1,073,000 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 50,000 | $715,500 | dollars as filed | |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 50,000 | $615,500 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 29,300 | $386,174 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 27,777 | $229,716 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 80,000 | $12,240 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001011438-26-000687 | this filing | 2026-11-13 |